New Intelligence Report for Olympus Medical Device Company - Global Developer of...

Mon Mar 31, 2008 9:00pm EDT

[-] Text [+]

New Intelligence Report for Olympus Medical Device Company - Global Developer of Optical and Electronic Technology

DUBLIN, Ireland--(Business Wire)--
Research and Markets
(http://www.researchandmarkets.com/reports/c87150) has announced the
addition of "Olympus Medical Device Company Intelligence Report" to
their offering.

Olympus Corporation, headquartered in Tokyo, Japan, develops and
manufactures products based on optical and electronic technology for
the consumer, scientific, healthcare and industrial markets. The
company's medical devices cover endoscopy, minimally-invasive surgery
and biomaterials. Olympus currently operates within five divisions;
Medical Systems, Imaging Systems, Life Science, Information &
Communication and Other, which includes its biomaterials operations.

The main focus of this profile is Olympus Medical Systems,
Olympus' largest operating division, accounting for 29% of the
company's total turnover in fiscal 2007. The division is a leading
manufacturer of gastrointestinal and surgical endoscopes, endotherapy
products, endoscopic ultrasound systems and related products. Products
are organised within two areas; gastrointestinal endoscopes and
minimally-invasive products, with the latter mainly comprising
surgical endoscopy products and endotherapy devices.

Gastrointestinal endoscopes are Olympus Medical Systems' largest
product area, accounting for 69% of its total revenue in fiscal 2007.
The company is the global market leader for these products, claiming
to hold over 70% of the global market. This product line includes
endoscopic video imaging systems, fibrescope systems,
bronchoendoscopes, endoscopic ultrasound systems, ultrasound probes,
ultrasound-guided needle puncture systems, cleaning, disinfecting and
sterilisation systems, medical treatment peripherals and ancillary
products. Olympus has made several key product introductions in this
area over the past year, including endoscopes designed to enhance
image quality and enable the visualisation of smaller details. It has
also launched its Endo Capsule capsule endoscope in the US, making it
only the second such product available in this market.

Sales of minimally-invasive products represent 31% of Olympus
Medical Systems' revenue. This product line includes endoscopy
products for a range of surgery applications, as well as endotherapy
products, treatment equipment and endoscopic surgery apparatus. A new
area for the minimally-invasive business is dental products. The
company began selling colour measurement equipment for dental clinics
and dental implant manufacturers in November 2006. Olympus plans to
continue to expand its involvement in the dental equipment market by
developing new products based on its optical and image processing
technologies.

In terms of geographic region, the international market is Olympus
Medical Systems' major source of revenue, with 77% of its sales coming
from outside of Japan in 2007. Olympus Medical Systems manufactures
most of its medical products in Japan, but also has manufacturing
bases in Germany through Olympus Winter & Ibe and Celon AG, and in the
UK through Olympus KeyMed.

In addition to Olympus Medical Systems, Olympus had operated its
Olympus Biomaterial Corporation (OBM) subsidiary since October 2004 to
specialise in biomaterials and tissue engineering. In April 2007,
Olympus merged OBM into a new joint venture with Terumo, called
Olympus Terumo Biomaterials Corporation. This new company also
includes Terumo's collagen business and aims to develop new products
in the fields of orthopaedics, dentistry, oral surgery, plastic
surgery and dermatology, based on the convergence of both companies'
technologies. The sales target for the biomaterials operations is Yen
5 billion within three years from its establishment.

Overview, Strategic Focus, Products, Research And Development,
International Activities, Financial Indicators, Key Corporate Events,
Mergers & Acquisitions, Joint Ventures, Minority Investments,
Agreements, Litigation

For more information visit
here

Research and Markets
Laura Wood, Senior Manager
Fax: +353 1 4100 980
press@researchandmarkets.com